Ads
related to: depakote information for patients with dementia treatmentalternativebee.com has been visited by 10K+ users in the past month
m4.havenhealthmgmt.org has been visited by 100K+ users in the past month
Search results
Results from the WOW.Com Content Network
Valproate may cause increased somnolence in the elderly. In a trial of valproate in elderly patients with dementia, a significantly higher portion of valproate patients had somnolence compared to placebo. In approximately one-half of such patients, there was associated reduced nutritional intake and weight loss. [4]
They used the National Patient Register to identify dementia cases and included 88,065 participants with dementia. The researchers then matched each dementia participant to 10 controls based on ...
The Dementia Training Australia funding an interactive online education package for deprescribing in dementia centered around the MATCH-D. It was a joint collaboration between the University of Western Australia, University of Tasmania, La Trobe University, Monash University, Alfred Health and FireFilms.
Vistaril (hydroxyzine) – an antihistamine for the treatment of itches and irritations, an antiemetic, as a weak analgesic, an opioid potentiator, and as an anxiolytic Vyvanse ( lisdexamfetamine ) – a pro-drug stimulant used to treat attention deficit hyperactivity disorder and binge eating disorder ; Vyvanse is converted into Dexedrine in vivo
The analysis showed that over a follow-up period of an average of 2.06 years for people on SGLT2 inhibitors, and 3.70 years for people on different antidiabetes drugs, there was a reduction in the ...
The scientists behind the study focused on sodium-glucose cotransporter-2 (SGLT-2) inhibitors, which they found significantly reduced dementia risk compared with another diabetes drug.
Alzheimer's disease (AD) is a neurodegenerative disease that usually starts slowly and progressively worsens. [2] It is the cause of 60–70% of cases of dementia. [2] [15] The most common early symptom is difficulty in remembering recent events. [1]
One study published in December 2022 found that semaglutide lowered the risk of dementia in patients with type 2 diabetes. Another study found that fellow GLP-1 medication liraglutide may protect ...
Ads
related to: depakote information for patients with dementia treatmentalternativebee.com has been visited by 10K+ users in the past month
m4.havenhealthmgmt.org has been visited by 100K+ users in the past month